Lowering immunosuppression is safe and effective to treat altered pattern of CMV infection in renal transplant recipients on valaciclovir prophylaxis

By Anglicheau D.   Lautrette A.   Scieux C.   Thervet E.   Martinez F.   Flamant M.   Morinet F.   Legendre C.  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2826-2827

Elsevier

Access to resources Recommend Favorite

Impact of OKT3 and polyclonal antibodies on symptomatic CMV infection in renal transplant recipients

By Yeung S.   Tong K.L.   Chan H.W.H.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1928-1929

Elsevier

Access to resources Recommend Favorite

Better clinical outcome in renal transplant recipients with peripheral blood microchimerism

By Sakamoto K.   Arita S.   Sakamaki T.   Yamada H.   Kusume K.   Yoshida T.   Okazaki Y.   Yamada K.   Gunji Y.   Shimada H.   Ochiai T.   Kashiwabara H.   Yokoyama T.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1793-1794

Elsevier

Access to resources Recommend Favorite

Leukocyte phenotype and function predicts infection risk in renal transplant recipients

By Blazic M.   Hutchinson P.   Holdsworth S.   Atkins R.C.   Chadban S.J.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3651-3651

Elsevier

Access to resources Recommend Favorite

Mycobacterial infection in renal transplant recipients

By Koselj M.   Kandus A.   Ales A.   Bren A.F.  

Transplantation Proceedings, Vol. 32, Iss. 1, 2000-02 ,pp. : 152-154

Elsevier

Access to resources Recommend Favorite